The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Cancer treatments gain strength when linked to genomic tests and therapy

In an interview with ETHealthworld, Dr Govind Babu, Associate Professor at Kidwai Memorial Institute of Oncology, Bengaluru, discusses the rapid advancements in genomics, how it impacts cancer care and what we need to do. Edited excerpts:

Today if you talk about Genomics, for most clinicians it is a very new term because clinicians as such are the end users of all these new technologies that come in and for it to percolate to routine use is rather difficult right now, but it is happening rapidly because we realise that without this we are nowhere today in treating our patients. So genomics as an integral part especially in oncology is very important.

When anything new comes, patients try to use it indiscriminately and this is a wrong thing because ultimately the process is put into disrepute. It is important that we have specific guidelines as to when [genomic] tests can be ordered, when they should be ordered and what is the benefit that our patient has from this.

[I]n the future, [genomics] is going to be the cornerstone for therapy of any cancer patient.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Today genomics has become an integral part of oncology: Dr Govind Babu

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend